Fever, a common symptom in clinical practice, often signals underlying infection or inflammation. Its management, however, can be complex due to varying etiologies and patient responses. This article aims to provide a comprehensive guide for managing fever in clinical practice.
Understanding the physiological mechanisms of fever is crucial. Fever results from an upward adjustment of the body's thermostat in the hypothalamus, often due to pyrogens. These may be exogenous, like bacterial toxins, or endogenous, such as cytokines. Understanding these mechanisms can aid in determining the cause of fever and guide treatment strategies.
Assessment of fever involves a thorough history, physical examination, and targeted investigations. Key aspects include duration, pattern, associated symptoms, and potential exposure to infectious agents. Depending on the clinical scenario, laboratory investigations may range from basic tests such as complete blood count and cultures, to more specific tests like serology or imaging.
Treatment of fever should be etiology-specific and patient-centered. Antipyretics, such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used. However, their use should be judicious, considering potential side effects. In fevers due to infection, appropriate antibiotics or antivirals should be employed. In non-infectious fevers, the underlying cause should be addressed.
Regular monitoring of the patient's temperature, response to treatment, and potential complications is essential. Follow-up is crucial, especially in cases where the fever is persistent or recurrent. This helps ensure that the chosen treatment strategy is effective and allows for adjustments as necessary.
Managing fever in clinical practice requires a comprehensive understanding of its mechanisms, thorough assessment, targeted treatment, and diligent follow-up. By adopting a systematic and patient-centered approach, clinicians can effectively manage fever, alleviating patient discomfort and potentially identifying and addressing serious underlying conditions.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation